1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
Understanding Age in the NIH Portfolio: Implementation of the NIH Inclusion Across the Lifespan Policy is sponsored by National Institutes of Health (NIH). This is a policy, not a direct grant program, that requires individuals of all ages (including children and older adults) be included in clinical research studies unless there are scientific or ethical reasons to exclude them.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Inclusion Across the Lifespan in Human Subjects Research | Grants & Funding U.S. Department of Health and Human Services National Institutes of Health Inclusion Across the Lifespan in Human Subjects Research Learn about the Inclusion Across the Lifespan policy and how to comply with this policy in applications and progress reports.
All human subjects research supported by NIH must include participants of all ages, including children and older adults, unless there are scientific or ethical reasons not to include them.
The purpose of the Inclusion Across the Lifespan Policy is to ensure individuals are included in clinical research in a manner appropriate to the scientific question under study so that the knowledge gained from NIH-funded research is applicable to all those affected by the researched diseases/conditions.
The policy expands the Inclusion of Children in Clinical Research Policy to include individuals of all ages, including child and older adult age ranges. The policy also requires that the age at enrollment of each participant be collected in progress reports. The Inclusion Across the Lifespan policy applies to all grant applications submitted for due dates on or after January 25, 2019 .
The policy also applies to solicitations for Research & Development contracts issued January 25, 2019 or later, and intramural studies submitted on/after this date. Ongoing, non-competing awards will be expected to comply with the policy at the submission of a competing renewal application. Research that was submitted before January 25, 2019 continues to be subject to the Inclusion of Children in Clinical Research Policy .
Applications and proposals involving human subjects research must address plans for including individuals across the lifespan in the PHS Human Subjects and Clinical Trial Information Form. Any age-related exclusions must include a rationale and justification based on a scientific or ethical basis. Refer to the PHS Human Subjects and Clinical Trial Information Form Instructions for complete guidance on what to address.
Scientific Review Groups will assess each application/proposal as being "acceptable" or "unacceptable" with regard to the age-appropriate inclusion or exclusion of individuals in the research project. For additional information on review considerations, refer to the Guidelines for the Review of Inclusion in Clinical Research (PDF, 222KB).
For information regarding the coding used to rate inclusion during peer review, see the list of NIH Peer Review Inclusion Codes (PDF, 179KB). NIH recipients/offerors must submit individual-level data on participant age at enrollment in Progress Reports . Age at enrollment must be provided along with other required inclusion variables in the Inclusion Enrollment Report.
Units for reporting age at enrollment range from minutes to years. Title Description Posted Date NOT-OD-18-116: NIH Policy and Guidelines on the Inclusion of Individuals Across the Lifespan as Participants in Research Involving Human Subjects This policy revises previous policy and guidelines regarding the inclusion of children in research.
Changes to the policy include 1) the applicability of the policy to individuals of all ages, 2) clarification of potentially acceptable reasons for excluding participants on age, and 3) a requirement to provide data on participant age at enrollment in progress reports.
December 19, 2017 NOT-OD-16-010: Inclusion of Children in Clinical Research: Change in NIH Definition For the purposes of inclusion policy, a child is defined as individuals under 18 years old. Applicants/offerors for NIH funding are still expected to justify the age range of the proposed participants in their clinical research.
October 13, 2015 NOT-OD-98-024: NIH Policy and Guidelines on The Inclusion of Children as Participants in Research Involving Human Subjects The goal of this policy is to increase the participation of children in research so that adequate data will be developed to support the treatment modalities for disorders and conditions that affect adults and may also affect children.
March 6, 1998 Title Description Posted Date Podcast: Allowable Costs for Clinical Research Participation This podcast discusses costs that may be allowable for clinical research related to planning and executing recruitment and retention of participants across the lifespan, women, and members of racial and ethnic minorities as appropriate to reach the scientific goals of the study.
Developing budgets, unintended costs, and other topics are also discussed. October 24, 2024 Podcast: Considering Language Access for Participants in NIH-Supported Clinical Research In this podcast, NIH staff explain how to consider language access when proposing research in a grant application. Language access policies, budgets and allowable costs, the importance of communication with research participants, and more are covered.
August 13, 2024 Infographic: Applying the Existing Dataset or Resource Definition (PDF) Infographic that walks through the elements of the existing dataset or resource definition to help users understand whether how it applies to their research.
August 2, 2024 Report: Inclusion statistics by NIH RCDC category Report on the representation of participants in human subjects studies from fiscal years 2018-2021 for FY2018 projects associated with the listed Research, Condition, and Disease Categorization (RCDC) categories.
October 31, 2023 Inclusion Across the Lifespan Case Studies (PDF) This document describes several mock studies as examples of how to consider the Inclusion Across the Lifespan policy in study design and eligibility criteria. Examples include commentary on scientific and ethical reasons that may be acceptable or unacceptable for age-based exclusion.
September 09, 2023 Allowable Costs Related to Participant Inclusion Activities in NIH Grants (PDF) This one-page resource highlights allowable costs for NIH grants that can be utilized to enhance inclusion through recruitment and retention activities. Allowable costs listed in the NIH Grants Policy Statement are provided with examples of inclusion-related activities.
August 10, 2023 Podcast: Inclusion Plans (Part 1): The Application In Part 1 of this NIH All About Grants podcast miniseries, NIH’s Inclusion Policy Officer Dawn Corbett tells us how to consider inclusion plans when putting together an application.
April 20, 2022 Podcast: Inclusion Plans (Part 2): Peer Review and Post-Award NIH’s Inclusion Policy Officer Dawn Corbett covers inclusion plans during peer review and post-award in Part 2 of this NIH All About Grants podcast miniseries.
April 20, 2022 Tip Sheet: Using the Participant-level Data Template (PDF) For research that falls under the Inclusion Across the Lifespan policy, submission of individual-level data is required in progress reports. This tip sheet serves as a quick guide for using the participant-level data template in the Human Subjects System to populate data in the cumulative (actual) enrollment table.
January 20, 2022 Resource List: Recruitment and Retention (PDF) Document listing resources on recruitment and retention of women, racial and ethnic minorities, and individuals across the lifespan. Resources include toolkits, articles, and more.
May 9, 2022 Video: Including Diverse Populations in NIH-Funded Clinical Research Video presentation by the NIH Inclusion Policy Officer for the NIH Grants Conference PreCon event, Human Subjects Research: Policies, Clinical Trials, & Inclusion, in December 2022. The presentation explains NIH inclusion policies and requirements for applicants and recipients. January 27, 2023 Inclusion Across The Lifespan-II Workshop Report (PDF, 1.
1 MB) Report summarizing the presentations and discussions that took place during the Inclusion Across the Lifespan II Workshop on September 2, 2020. December 10, 2020 Open Mike Blog: Some Thoughts Following the NIH Inclusion Across the Lifespan II Workshop Blog post by NIH's Deputy Director of Extramural Research, Dr. Mike Lauer, highlighting the Inclusion Across the Lifespan II Workshop.
December 10, 2020 Video Tutorial: Entering Inclusion Data Using the Participant Level Data Template This video tutorial demonstrates how to enter inclusion data using the Participant Level Data Template in the Human Subjects System (HSS). February 26, 2020 Infographic: Guidance for Applying the Inclusion Across the Lifespan Policy (PDF) At-a-glance guidance for complying with the policy in applications and progress reports.
May 3, 2019 Podcast: NIH's Inclusion Across the Lifespan Policy The "All About Grants" podcast featuring an interview with the NIH Inclusion Policy Officer about the Inclusion Across the Lifespan policy. August 27, 2018 Human Subjects System (HSS) Overview and Training Information As of June 9, 2018, the Human Subjects System (HSS) replaced the Inclusion Management System (IMS).
Similar to IMS, HSS is used by NIH staff, grant applicants, and recipients to manage human subjects information, including inclusion information.
May 25, 2018 Open Mike Blog: The Inclusion Across the Lifespan Policy Blog post by Dr. Mike Lauer, Deputy Director of Extramural Research, and Dawn Corbett, NIH Inclusion Policy Officer, titled Understanding Age in the NIH Portfolio: Implementation of the NIH Inclusion Across the Lifespan Policy November 13, 2018 Workshop Summary: Inclusion Across the Lifespan Workshop Report (PDF) Summary report from the Inclusion Across the Lifespan workshop held June 1-2, 2017 July, 2017 DHSR One Pager of Resources for External Users (PDF, 170 KB) National Institute on Aging National Institute of Child Health and Human Development Have additional questions?
Contact your program officer or the Inclusion policy team: [email protected] This page last updated on: February 27, 2025 For technical issues E-mail OER Webmaster
According to the current listing, eligibility includes: Not a direct grant program, but rather a policy that affects eligibility and inclusion criteria for various NIH-funded clinical research studies. Researchers applying for NIH grants should adhere to this policy. Confirm the full requirements in the official notice before applying.
Understanding Age in the NIH Portfolio: Implementation of the NIH Inclusion Across the Lifespan Policy is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article